Provided by Tiger Trade Technology Pte. Ltd.

BIOHEART-B

3.350
+0.89036.18%
Volume:853.00K
Turnover:2.68M
Market Cap:815.45M
PE:-10.07
High:3.570
Open:2.460
Low:2.460
Close:2.460
52wk High:10.770
52wk Low:1.820
Shares:243.42M
HK Float Shares:235.70M
Volume Ratio:0.52
T/O Rate:0.36%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.333
ROE:-10.59%
ROA:-5.72%
PB:1.62
PE(LYR):-10.07
PS:15.70

Loading ...

Bio-heart Biological Stent Approved in China

MT Newswires Live
·
Yesterday

BIOHEART-B Receives NMPA Approval for its Bioresorbable Drug-Eluting Stent System

Stock News
·
Yesterday

Shanghai Bio-heart Says NMPA Approves Bioheart Bioabsorbable Drug-eluting Coronary Stents

Reuters
·
Yesterday

Shanghai Bio-heart Biological Technology Co - Nmpa Approves Bioheart® Bioabsorbable Drug-eluting Stents on June 29, 2029

THOMSON REUTERS
·
Yesterday

BIOHEART-B Appoints Wang Li as Board Chairman

Stock News
·
Jun 26

Shanghai Bio-heart Re-elects Philip Li Wang as Chairman of Board’s Third Term

Reuters
·
Jun 26

Bio-heart secures Israeli registration for Iberis® RDN system, strengthening global rollout with Biosensors partnership

Bulletin Express
·
Jun 09

BIOHEART-B's Iberis® Renal Denervation System Gains Registration in Israel

Stock News
·
Jun 09

BIOHEART-B Reports No Share Capital Changes, Confirms Public Float Compliance for May 2026

Bulletin Express
·
Jun 04

BIOHEART-B Sets 26 June AGM to Abolish Supervisory Board, Seek 20% Share Issue Mandate and Confirm No 2025 Dividend

Bulletin Express
·
Jun 01

Shanghai Bio-heart Schedules 2025 AGM for 26 June 2026; Agenda Includes Profit Distribution, Board Re-election and 20% Share-Issue Mandate

Bulletin Express
·
Jun 01

Shanghai Bio-heart Bio-heart announces annual shareholder meeting

Reuters
·
Jun 01

Bio-heart Proposes Scrapping Board of Supervisors and Updating Articles Ahead of 2026 AGM

Bulletin Express
·
May 26

Asian Equity Special Opportunities Portfolio Master Fund Boosts Stake in BIOHEART-B (02185) by 699,800 Shares at HK$3.82 Each

Stock News
·
May 19

RAYS Capital Partners Limited Acquires Additional 789,800 Shares in BIOHEART-B at Average Price of HK$3.82 Each

Stock News
·
May 19

Shanghai Bio-heart's Iberis Device Registered in Vietnam

MT Newswires Live
·
May 12

BIOHEART-B's Iberis® RDN System Receives Registration Approval in Vietnam

Stock News
·
May 11

Shanghai Bio-Heart Biological Technology Co Ltd - Iberis Rdn System Completes Registration in Vietnam

THOMSON REUTERS
·
May 11

Shanghai Bio-heart says Iberis renal denervation system gains Vietnam registration

Reuters
·
May 11

Bio-heart Confirms Stable Share Capital and Sufficient Public Float in April 2026 Monthly Return

Bulletin Express
·
May 06